Table: Pharmarise Holdings -Q1 group results

Pharmarise Holdings

02/10/2023 09:45

Oct 2 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Aug 31, 2023        Aug 31, 2022     May 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               13.47               12.86            53.55    
                   (+4.7 pct)          (-1.5 pct)       (+2.9 pct)  
  Operating          331 mln             348 mln            1.48    
                   (-5.0 pct)          (+9.7 pct)       (+2.7 pct)  
  Recurring          331 mln             341 mln            1.42    
                   (-2.8 pct)          (+1.8 pct)       (-0.6 pct)  
  Net                123 mln             111 mln          449 mln   
                   (+11.2 pct)         (+75.0 pct)      (+34.9 pct) 
  EPS               13.11 yen           11.88 yen        46.14 yen  
  EPS Diluted       9.93 yen            8.99 yen                    
  Ann Div                               14.00 yen        20.00 yen  
  -Q2 div                                  NIL              NIL     
  -Q4 div                               14.00 yen        20.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T